JFDA engages in IMDRF’s working groups, says director

Amman: Jordan Food and Drug Administration (JFDA) has recently begun its participation in the working groups of the International Medical Device Regulators Forum (IMDRF). These groups focus on "adequate" regulatory practices for assessing the technical requirements for registering medical devices and supplies and clinical evidence and enhanced reporting of side effects of medical supplies. In a statement Wdnesday, JFDA Director General, Dr. Nizar Mheidat, said the administration joined the IMDRF at the end of last March, making Jordan the first country in the Middle East to meet the requirements for membership in the forum. Mheidat added that the JFDA's membership would support the Kingdom's industrial sector of medical supplies and devices, enhance compliance of its products with global quality and safety requirements, enhance their competitiveness in the local and global markets, and raise quality and efficiency of these medical imports to be sold to citizens at "reasonable" prices. Mheidat noted this m embership will contribute to enhance joint cooperation and coordination with global regulatory bodies, facilitate access to the "latest" legislation in this field, and provide an opportunity to exchange expertise and participate in the IMDRF's meetings. Mheidat pointed out that the JFDA's membership came in recognition of its "distinguished" efforts in the field of legislative systems for medical supplies and devices. Additionally, he stated that the step also recognizes JFDA's steps to align regulatory procedures with global foundations, and "high professional" performance in the fields of registering, trading, and monitoring medical devices and supplies. Source: Jordan News Agency